Bevacizumab mitigates codon-specific effects of trifluridine/tipiracil on efficacy outcome parameters in metastatic colorectal cancer

  • B. Doleschal*
  • , H. Taghizadeh
  • , T. Lentner
  • , J.m. Riedl
  • , J. Granitzer
  • , D. Morariu
  • , J. Decker
  • , K.j. Aichberger
  • , G. Webersinke
  • , P. Kirchweger
  • , A. Petzer
  • , H. Rumpold
    • *Corresponding author for this work

Research output: Journal article (peer-reviewed) › Journal article

2   Link opens in a new tab Citations (Scopus)

Fingerprint

Dive into the research topics of 'Bevacizumab mitigates codon-specific effects of trifluridine/tipiracil on efficacy outcome parameters in metastatic colorectal cancer'. Together they form a unique fingerprint.
Sort by

Pharmacology, Toxicology and Pharmaceutical Science